Cargando…
Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105
Background Expression of angiogenic markers determined by microvessel density (MVD) could be used as a reliable predictor of prognosis and as a potential target for antiangiogenic therapy in different categories of non-Hodgkin lymphoma (NHL). Aims The aim of this study was to evaluate MVD using im...
Autores principales: | Kataria, Sant Prakash, Malik, Shivani, Yadav, Roomi, Kapil, Raman, Sen, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205556/ https://www.ncbi.nlm.nih.gov/pubmed/34149231 http://dx.doi.org/10.1055/s-0041-1726569 |
Ejemplares similares
-
CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ
por: Marcianò, Antonia, et al.
Publicado: (2021) -
Evaluation of microvessel density with CD31 and CD105 in patients with psoriasis under methotrexate and acitretin therapy
por: Zemheri, Ebru, et al.
Publicado: (2020) -
Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015) -
Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques
por: Fukumitsu, Ryu, et al.
Publicado: (2013) -
Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma
por: Marioni, Gino, et al.
Publicado: (2020)